A combination of pertuzimab and Enhertu can slow disease progression and improve survival in people with HER2-positive ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

High-level results from the DESTINY-Breast09 Phase III trial revealed that ENHERTU® (fam-trastuzumab deruxtecan-nxki), in ...

Immunotherapy let some cancer patients with mismatch repair deficient tumors completely avoid surgery, chemo and radiation, a ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

“With the majority of breast cancer cases historically considered HR positive, HER2 negative, additional treatment options are needed to improve outcomes for patients with metastatic disease ...

In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing ...

Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR ...

CELEBRITY Big Brother's Trisha Goddard has revealed the "vicious" side effects of the "wonder' cancer drug she's taking that's prolonging her life. Trisha, 67, was diagnosed with terminal breast ...

Faulkner’s general practitioner referred her to the emergency department, where she underwent testing and was diagnosed with a rare type of blood cancer called Acute Myeloid Leukaemia.

WASHINGTON (7News) — The Washington D.C. Firefighters Association is holding screenings for its firefighters who may be at risk for esophageal cancer. April is Esophageal Cancer Awareness Month.